Table 2.
Clinical efficacy of laparoscope-assisted CHIPC in patients with gastric cancer complicated by malignant ascites
| Case No. | Therapeutic outcome | Port-site seeding (+/-) |
KPS mark |
Survival time (mo) | Death/living | |
| Before treatment | After treatment | |||||
| 1 | CR | - | 40 | 80 | 9 | Death |
| 2 | CR | - | 60 | 90 | 7 | Death |
| 3 | CR | - | 60 | 70 | 5 | Death |
| 4 | CR | - | 50 | 80 | 5 | Death |
| 5 | CR | - | 70 | 90 | 7 | Death |
| 6 | CR | - | 50 | 70 | 4 | Death |
| 7 | PR | + | 40 | 60 | 2 | Death |
| 8 | CR | - | 50 | 70 | 4 | Death |
| 9 | CR | - | 50 | 90 | 5 | Death |
| 10 | CR | - | 60 | 80 | 5 | Death |
| 11 | CR | - | 60 | 80 | 4 | Death |
| 12 | PR | + | 50 | 70 | 3 | Death |
| 13 | CR | - | 40 | 80 | 7 | Death |
| 14 | CR | - | 70 | 80 | 7 | Living |
| 15 | CR | - | 60 | 70 | 4 | Living |
| 16 | CR | - | 60 | 80 | 6 | Living |
KPS: Karnofsky; CR: Complete remission; PR: Partial remission.